Novel approaches to drug discovery for the treatment of type 2 diabetes
Author:
Affiliation:
1. Shanghai Institute of Materia Medica, Key Laboratory of Receptor Research, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
Publisher
Informa Healthcare
Subject
Drug Discovery
Link
https://www.tandfonline.com/doi/pdf/10.1517/17460441.2014.941352
Reference101 articles.
1. Mechanisms of Diabetic Complications
2. New drug targets for type 2 diabetes and the metabolic syndrome
3. Genome-wide association studies and type 2 diabetes
4. Physiologic Characterization of Type 2 Diabetes–Related Loci
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diabetes: a review of its pathophysiology, and advanced methods of mitigation;Current Medical Research and Opinion;2024-04-04
2. α-Glucosidase immobilization on the metal–organic framework composite membrane for enzyme inhibitor screening;New Journal of Chemistry;2024
3. Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4‐oxadiazole derivatives: Synthesis, in vitro screening, and computational studies;Archiv der Pharmazie;2023-10-08
4. Imidazopyridine-Based Thiazole Derivatives as Potential Antidiabetic Agents: Synthesis, In Vitro Bioactivity, and In Silico Molecular Modeling Approach;Pharmaceuticals;2023-09-13
5. A novel electrochemical sensor based on Cu(Ⅱ) metal organic framework for the determination of metformin;Microchemical Journal;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3